Provided by Tiger Trade Technology Pte. Ltd.

Telomir Pharmaceuticals

1.19
+0.01000.85%
Volume:35.13K
Turnover:41.56K
Market Cap:81.84M
PE:-1.31
High:1.20
Open:1.17
Low:1.17
Close:1.18
52wk High:2.09
52wk Low:0.8885
Shares:68.78M
Float Shares:45.73M
Volume Ratio:1.20
T/O Rate:0.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9106
EPS(LYR):-0.3300
ROE:-213.10%
ROA:-122.81%
PB:16.26
PE(LYR):-3.61

Loading ...

Nov 22, 2024

Major Issues Report

Form 8-K - Current report
Nov 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 27, 2024

Major Issues Report

Form 8-K - Current report
Sep 03, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 22, 2024

Major Issues Report

Form 8-K - Current report
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 15, 2024

Major Issues Report

Form 8-K - Current report
Apr 12, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 13, 2024

Major Issues Report

Form 8-K - Current report
Feb 06, 2024

Correspondence

Form CORRESP - Correspondence
Feb 06, 2024

Correspondence

Form CORRESP - Correspondence
Jan 03, 2024

Correspondence

Form CORRESP - Correspondence
Jan 03, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 19, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Dec 14, 2023

Correspondence

Form CORRESP - Correspondence
Dec 14, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 14, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933